Two Sigma Securities, LLC Nymox Pharmaceutical Corp Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.19 - $0.49 $1,821 - $4,696
-9,585 Reduced 44.95%
11,737 $2,000
Q1 2023

May 15, 2023
BUY
$0.33 - $0.5 $412 - $625
1,250 Added 6.23%
21,322 $7,000
Q4 2022

Feb 14, 2023
BUY
$0.28 - $0.74 $2,423 - $6,406
8,657 Added 75.84%
20,072 $6,000
Q3 2022

Nov 14, 2022
BUY
$0.22 - $0.61 $2,511 - $6,963
11,415 New
11,415 $5,000

Others Institutions Holding NYMX

# of Institutions
6
Shares Held
150K
Call Options Held
0
Put Options Held
0
View Full List

About NYMOX PHARMACEUTICAL CORP

NYMX Quotes by TradingView
  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email